These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Comarmond C; Pagnoux C; Khellaf M; Cordier JF; Hamidou M; Viallard JF; Maurier F; Jouneau S; Bienvenu B; Puéchal X; Aumaître O; Le Guenno G; Le Quellec A; Cevallos R; Fain O; Godeau B; Seror R; Dunogué B; Mahr A; Guilpain P; Cohen P; Aouba A; Mouthon L; Guillevin L; Arthritis Rheum; 2013 Jan; 65(1):270-81. PubMed ID: 23044708 [TBL] [Abstract][Full Text] [Related]
4. Long-Term Followup of a Multicenter Cohort of 101 Patients With Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss). Durel CA; Berthiller J; Caboni S; Jayne D; Ninet J; Hot A Arthritis Care Res (Hoboken); 2016 Mar; 68(3):374-87. PubMed ID: 26315340 [TBL] [Abstract][Full Text] [Related]
5. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Gayraud M; Guillevin L; le Toumelin P; Cohen P; Lhote F; Casassus P; Jarrousse B; Arthritis Rheum; 2001 Mar; 44(3):666-75. PubMed ID: 11263782 [TBL] [Abstract][Full Text] [Related]
6. A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients. Moosig F; Bremer JP; Hellmich B; Holle JU; Holl-Ulrich K; Laudien M; Matthis C; Metzler C; Nölle B; Richardt G; Gross WL Ann Rheum Dis; 2013 Jun; 72(6):1011-7. PubMed ID: 22887848 [TBL] [Abstract][Full Text] [Related]
7. Churg-Strauss syndrome. Greco A; Rizzo MI; De Virgilio A; Gallo A; Fusconi M; Ruoppolo G; Altissimi G; De Vincentiis M Autoimmun Rev; 2015 Apr; 14(4):341-8. PubMed ID: 25500434 [TBL] [Abstract][Full Text] [Related]
8. Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patients. Ribi C; Cohen P; Pagnoux C; Mahr A; Arène JP; Puéchal X; Carli P; Kyndt X; Le Hello C; Letellier P; Cordier JF; Guillevin L; Arthritis Rheum; 2010 Apr; 62(4):1186-97. PubMed ID: 20131268 [TBL] [Abstract][Full Text] [Related]
9. Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy. Pagnoux C; Quéméneur T; Ninet J; Diot E; Kyndt X; de Wazières B; Reny JL; Puéchal X; le Berruyer PY; Lidove O; Vanhille P; Godmer P; Fain O; Blockmans D; Bienvenu B; Rollot F; Aït el Ghaz-Poignant S; Mahr A; Cohen P; Mouthon L; Perrodeau E; Ravaud P; Guillevin L; Arthritis Rheumatol; 2015 Apr; 67(4):1117-27. PubMed ID: 25693055 [TBL] [Abstract][Full Text] [Related]
10. Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss). Nguyen Y; Guillevin L Semin Respir Crit Care Med; 2018 Aug; 39(4):471-481. PubMed ID: 30404114 [TBL] [Abstract][Full Text] [Related]
11. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis. Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome). Mouthon L; Dunogue B; Guillevin L J Autoimmun; 2014; 48-49():99-103. PubMed ID: 24530234 [TBL] [Abstract][Full Text] [Related]
14. Five factor score of more than 1 is associated with relapse during the first 2 year-follow up in patients with eosinophilic granulomatosis with polyangiitis. Kim DS; Song JJ; Park YB; Lee SW Int J Rheum Dis; 2017 Sep; 20(9):1261-1268. PubMed ID: 28261989 [TBL] [Abstract][Full Text] [Related]
15. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients. Guillevin L; Lhote F; Cohen P; Jarrousse B; Lortholary O; Généreau T; Léon A; Bussel A Arthritis Rheum; 1995 Nov; 38(11):1638-45. PubMed ID: 7488285 [TBL] [Abstract][Full Text] [Related]
16. Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial. Puéchal X; Pagnoux C; Baron G; Quémeneur T; Néel A; Agard C; Lifermann F; Liozon E; Ruivard M; Godmer P; Limal N; Mékinian A; Papo T; Ruppert AM; Bourgarit A; Bienvenu B; Geffray L; Saraux JL; Diot E; Crestani B; Delbrel X; Sailler L; Cohen P; Le Guern V; Terrier B; Groh M; Le Jeunne C; Mouthon L; Ravaud P; Guillevin L; Arthritis Rheumatol; 2017 Nov; 69(11):2175-2186. PubMed ID: 28678392 [TBL] [Abstract][Full Text] [Related]
17. [Churg-Strauss syndrome: clinical features and long-term follow-up of 16 patients]. Lou J; Xu WB Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):524-8. PubMed ID: 19567070 [TBL] [Abstract][Full Text] [Related]
18. Optimal therapy and prospects for new medicines in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). Pagnoux C; Groh M Expert Rev Clin Immunol; 2016 Oct; 12(10):1059-67. PubMed ID: 27191665 [TBL] [Abstract][Full Text] [Related]